November 3, 2015
http://www.epigenomics.com/en/news-investors/news-media/press-releases/latest-news/article/epigenomics-ag-gibt-ein-update-ueber-bluttests-zur-krebsfrueherkennung-auf-der-jahrestagung-2015-der.html
October 5, 2015
Curetis and Acumen to Collaborate on Unyvero Sepsis Test and ASEAN Distribution Curetis licenses Acumen’s proprietary sepsis biomarker panel for use with Unyvero Platform Diagnostics Development […]
September 28, 2015
Curetis Unyvero (Video): In vitro diagnostic for rapid pathogen and antibiotic resistance profiling. Select link below to view video : https://www.youtube.com/watch?v=khQETD4qZio
September 25, 2015
Curetis Enters into Distribution Agreement to Expand Commercial Activities into Greater China Exclusive Unyvero distribution agreement with Beijing Clear Biotech Co., Ltd. for Mainland China, Hong […]
August 12, 2015
Select link below to view article: http://www.theguardian.com/science/2015/may/07/personalised-cancer-treatment-a-step-closer-with-worlds-first-living-biobank
July 15, 2015
Epigenomics and BioChain Announce Inclusion of Septin9 Test in Chinese Screening Guideline Epigenomics AG : Epigenomics and BioChain announce the inclusion of their proprietary blood-based Septin9 […]
July 8, 2015
Curetis Initiates Next Phase of Unyvero U.S. FDA Trial in Lower Respiratory Tract Infections First patient enrolled in prospective arm of IVD trial Study to include […]
June 24, 2015
Select link below to view press release: http://akampioneer.com/company-news/company-news-curetis%E2%80%99-unyvero-system-selected-for-global-phase-iii-antibiotics-trial.html
May 19, 2015
Select link below to view CAP article: http://www.captodayonline.com/maldi-microbiology-set-stun/
